#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic candida Prolymphocytic leukaemia Acute graft versus host disease in liver Amyotrophic lateral sclerosis Aplastic anaemia Cervix carcinoma Encephalitis autoimmune Osteosarcoma Retinoblastoma Transferrin decreased IPEX syndrome Brain abscess Kaposi's sarcoma Marginal zone lymphoma Squamous cell carcinoma of the vulva More trials…

    Learn about Rare Diseases

    KBG syndrome Niemann-Pick disease – Trials in Disease Congenital hypotransferrinaemia – Life with Disease Immunodeficiency congenital – Basic Information Pulmonary sarcoidosis – Treatment Cholangitis sclerosing – Life with Disease Primary mediastinal large B-cell lymphoma – Basic Information Myxofibrosarcoma – Trials in Disease Osteosarcoma Hereditary angioedema – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pc14586 Ramipril Esmolol Hydrochloride Follitropin Delta Zetomipzomib Valsartan Prilocaine Entinostat STREPTOCOCCUS VIRIDANS Vinflunine GSKVX000000025896 Pritelivir ALN-4324 Parsaclisib Hydrochloride Belumosudil Mesilate Histidine Telitacicept Iph6501 Berzosertib Mps-102 More therapies…

    Learn about Your Condition

    Partial seizures Weaning failure Arterial tortuosity syndrome Periarthritis Pain in extremity Hypochromic anaemia Endometrial cancer stage III Double hit lymphoma Primary hyperoxaluria Stress cardiomyopathy Ovarian cancer metastatic Sexual dysfunction Immune-mediated renal disorder Acne Small for dates baby More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Crovalimab
    • Eculizumab
    Belgium Czechia Estonia France Germany Greece +7

  • Study on Long-Term Safety and Efficacy of Etranacogene Dezaparvovec for Adults with Severe or Moderately Severe Hemophilia B

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    Investigated Drugs:
    • Etranacogene Dezaparvovec
    Germany The Netherlands

  • Study on the Safety and Effectiveness of Giroctocogene Fitelparvovec for Adult Men with Moderate to Severe Hemophilia A

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Giroctocogene Fitelparvovec
    France Germany Greece Spain Sweden

  • Study of Pirtobrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Pirtobrutinib
    France Italy Poland

  • Long-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Valoctocogene Roxaparvovec
    Belgium France Germany Italy Spain

  • Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Nilotinib
    Bulgaria Czechia France Germany Greece Hungary +4
Previous Page
1 … 71 72 73 74 75 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!